Page last updated: 2024-08-24

cortivazol and Adenocarcinoma, Basal Cell

cortivazol has been researched along with Adenocarcinoma, Basal Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Evers, BM; Johnson, B; Lawrence, JL; Srinivasan, G; Thompson, EB; Thompson, JC; Townsend, CM1

Other Studies

1 other study(ies) available for cortivazol and Adenocarcinoma, Basal Cell

ArticleYear
Cortivazol increases glucocorticoid receptor expression and inhibits growth of hamster pancreatic cancer (H2T) in vivo.
    Pancreas, 1993, Volume: 8, Issue:1

    Topics: Adenocarcinoma; Animals; Cricetinae; Gene Expression; Glucocorticoids; Male; Mesocricetus; Pancreatic Neoplasms; Pregnatrienes; Receptors, Glucocorticoid; RNA, Messenger; RNA, Neoplasm

1993